Cleveland Clinic Abu Dhabi, which is part of the M42 group, has successfully performed the world’s first transcontinental robotic-assisted focal therapy for prostate cancer. This innovative procedure was conducted remotely, marking a significant advancement in the treatment of this disease.

Credit: M42

The procedure utilized advanced ultrasound technology, allowing specialists to provide care from thousands of miles away. This achievement highlights the potential of combining robotics and telemedicine to improve patient outcomes in cancer treatment.

The team at Cleveland Clinic Abu Dhabi emphasized the importance of this milestone, stating that it represents a leap forward in the capabilities of robotic-assisted therapies. The procedure is expected to set a new standard for how prostate cancer is treated globally, showcasing the clinic’s commitment to pioneering medical advancements.